AYTU Aytu BioScience Secures Exclusive U.S. Distribution Agreement for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test https://finance.yahoo.com/news/aytu...u-120500962.html?soc_src=hl-viewer&soc_trk=tw
Aytu BioScience Establishes COVID-19 IgG/IgM Rapid Test Product Inquiry Procedure for Healthcare Professionals and Institutions Healthcare professionals, institutions, and other interested parties with questions about the Company's recently licensed COVID-19 IgG/IgM Rapid Test are asked to send email inquiries to [email protected] Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today the establishment of a COVID-19 inquiry procedure to ensure the company adequately responds to inbound inquires from professionals and the public. In order to streamline and effectively capture the significant number of inbound inquiries related to the COVID-19 IgG/IgM Rapid Test, the company requests healthcare professionals, institutions, and other interested parties to send email inquiries to a COVID-19-dedicated email address. Inquiries should be directed via email to [email protected]. Josh Disbrow, Chief Executive Officer of Aytu BioScience, commented, "Aytu BioScience is working to be as responsive as possible to the numerous inbound inquiries we're receiving relating to the COVID-19 Rapid Test. With the high volume of inbound calls and emails the Company has received, we want to ensure effective communication and timely response to these calls and emails." The COVID-19 IgG/IgM Rapid Test is a solid phase immunochromatographic assay used in the rapid, qualitative and differential detection of IgG and IgM antibodies to the 2019 Novel Coronavirus in human whole blood, serum or plasma. This point-of-care test has been validated in a 113 patient clinical trial and has received CE marking. It is currently one of only a few tests used for coronavirus screening in China.
AYTU Englewood company says it can get COVID-19 test results in 2-10 minutes. https://news.yahoo.com/colorado-company-says-covid-19-030902302.html
AYTU News! Aytu BioScience Expands Its Distribution Rights for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test to Canada and Mexico Company Expects to Seek Regulatory Clearance Under Health Canada and COFEPRIS Expedited Clearance Procedures. https://www.otcmarkets.com/stock/AYTU/news/story?e&id=1557017
AYTU is making a run for the top after the company announced that it has been cleared to commercialize its coronavirus rapid test. Aytu BioScience Submits Notice of Commercialization to the FDA, Allowing for Company's Distribution of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test https://finance.yahoo.com/news/aytu...mmercialization-120000047.html?.tsrc=fin-srch
AYTU AYTU Announces Delay of Annual Meeting of Stockholders Due to Colorado's "Shelter in Place" Order...
$AYTU Aytu BioScience Announces Receipt of Initial Shipment of 100,000 COVID-19 IgG/IgM Point-of-Care Rapid Tests; Additional 500,000 Tests on Order Initial Shipment of 2-10 Minute COVID-19 Rapid Tests Received at Company's Englewood, Colorado Facility. https://finance.yahoo.com/news/aytu...l-120000266.html?soc_src=social-sh&soc_trk=tw
AYTU Aytu BioScience Announces First Commercial Shipment of its 2-10 Minute COVID-19 IgG/IgM Point-of-... https://finance.yahoo.com/news/aytu-bioscience-announces-first-commercial-120000394.html?soc_src=hl-viewer&soc_trk=tw
AYTU Aytu Featured on NBC and Fox News (VIDEO): "Denver officers, firefighters will be among first in US to get rapid COVID-19 tests"; "Denver scores 2,700 COVID-19 rapid tests for first responders" https://finance.yahoo.com/news/aytu...s-120000734.html?soc_src=social-sh&soc_trk=tw
$ATYU Aytu BioScience Receives $23.0 Million from Warrant Exercises Cash and Cash Equivalents of Approximately $62.5 on March 31, 2020 https://finance.yahoo.com/news/aytu-bioscience-receives-23-0-120000651.html
$AYTU News! Aytu BioScience Licensee SUDA Pharmaceuticals Expands ZolpiMist Global Footprint Through Exclusive Licensing Agreement with Mitsubishi Tanabe Pharma Corporation https://finance.yahoo.com/news/aytu...t-120000860.html?soc_src=social-sh&soc_trk=tw
AYTU News! Aytu BioScience Announces Updated Annual Shareholder Meeting Date and Virtual Room Access https://finance.yahoo.com/news/aytu-bioscience-announces-updated-annual-120000862.html
AYTU News! 4/13/20 Aytu BioScience Consumer Health Subsidiary Launches Regoxidine(R), an FDA Approved Hair Regrowth Treatment Foam that Contains 5% Minoxidil and Targets Over 11 Million U.S. Consumers Who Purchased Hair Regrowth Products in 2019 https://finance.yahoo.com/news/aytu-bioscience-consumer-health-subsidiary-120000358.html
$AYTU 4/15 News! Aytu BioScience Provides Update on its Licensed COVID-19 IgG/IgM Rapid Test Supply and Ongoing U.S. Distribution https://finance.yahoo.com/news/aytu-bioscience-provides-licensed-covid-120000235.html
$AYTU 4/16 News! Aytu BioScience Announces Positive Results from an Independently Conducted Clinical Study of the Company's Licensed COVID-19 IgG/IgM Point-of-Care Rapid Test https://finance.yahoo.com/news/aytu-bioscience-announces-positive-results-120000218.html
$AYTU 4/17 News! Aytu BioScience Confirms Export and Incoming Delivery of COVID-19 IgG/IgM Rapid Tests https://www.accesswire.com/585517/A...oming-Delivery-of-COVID-19-IgGIgM-Rapid-Tests
$AYTU Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus Treatment Cedars-Sinai-Developed ‘Healight' Medical Device Platform Technology Being Studied as a Potential First-in-Class COVID-19 Treatment" data-reactid="12">Cedars-Sinai-Developed ‘Healight' Medical Device Platform Technology Being Studied as a Potential First-in-Class COVID-19 Treatment Conference Call Scheduled for Tuesday, April 21, 2020 at 4:30 pm ET" data-reactid="13">Conference Call Scheduled for Tuesday, April 21, 2020 at 4:30 pm ET https://finance.yahoo.com/news/aytu...l-120000824.html?soc_src=social-sh&soc_trk=tw
Aytu BioScience Announces Publication of Results from Natesto Spermatogenesis Study in Journal of Urology *Nasally-Administered Natesto Testosterone Replacement Therapy Increases Serum Testosterone, Improves Hypogonadal Symptoms While Simultaneously Preserving Semen Parameters and Gonadotropin Hormones https://newsfilter.io/articles/aytu...ournal-of-ur-af77d34c79e5df78f4dc5daf163648e9
AYTU Aytu BioScience Announces Results from Annual Stockholders Meeting https://finance.yahoo.com/news/aytu...l-120000500.html?soc_src=hl-viewer&soc_trk=tw